Literature DB >> 19561411

Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies.

Vanderson Rocha1, Mohamad Mohty, Eliane Gluckman, Bernard Rio.   

Abstract

Cord blood is an unlimited source of haematopoietic stem cells for allogeneic haematopoietic stem cell transplants. During the past 5 years, the number of adults transplanted with cord blood cells from unrelated donors has exceeded the number of transplants in children, as a result of better definitions of cord blood unit choice, an increased number of cord blood units available for transplantation worldwide, comparable results of unrelated cord blood transplantation (UCBT) with human leukocyte antigen-matched unrelated bone marrow transplantation, the use of double cord blood transplantation and the use of UCBT after a reduced-intensity conditioning (RIC) regimen. In spite of the encouraging results of RIC UCBT in single-centre studies, the number of patients given this strategy is still limited and follow-up is still too short to draw definitive conclusions. Moreover, many questions remain to be answered such as: (1) the type of patients and disease populations that may benefit most from this strategy; (2) the best conditioning regimen to use; (3) the criteria of cord blood choice in this setting; and (4) factors predictive of outcomes after RIC UCBT. This paper will summarize some recent results of RIC UCBT for adults with haematological malignancies.

Entities:  

Mesh:

Year:  2009        PMID: 19561411     DOI: 10.1097/01.cco.0000357473.58411.1b

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  11 in total

Review 1.  Reduced-intensity conditioned allogeneic SCT in adults with AML.

Authors:  R Reshef; D L Porter
Journal:  Bone Marrow Transplant       Date:  2015-03-02       Impact factor: 5.483

2.  Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis.

Authors:  Hongliang Sun; Ying Tsai; Irena Nowak; Jane Liesveld; Yuhchyau Chen
Journal:  Stem Cell Res       Date:  2012-05-14       Impact factor: 2.020

3.  Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.

Authors:  Nelli Bejanyan; Claudio G Brunstein; Qing Cao; Aleksandr Lazaryan; Xianghua Luo; Julie Curtsinger; Rohtesh S Mehta; Erica Warlick; Sarah A Cooley; Bruce R Blazar; Jeffrey S Miller; Daniel Weisdorf; John E Wagner; Michael R Verneris
Journal:  Blood Adv       Date:  2018-04-24

Review 4.  An overview of the progress on double umbilical cord blood transplantation.

Authors:  Anastasia Sideri; Nikolaos Neokleous; Philippe Brunet De La Grange; Bernadette Guerton; Marie-Caroline Le Bousse Kerdilles; Georges Uzan; Corina Peste-Tsilimidos; Eliane Gluckman
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

5.  Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.

Authors:  Claudio G Brunstein; Mary Eapen; Kwang Woo Ahn; Frederick R Appelbaum; Karen K Ballen; Richard E Champlin; Corey Cutler; Fangyu Kan; Mary J Laughlin; Robert J Soiffer; Daniel J Weisdorf; Anne Woolfrey; John E Wagner
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

6.  Characteristics of chronic GVHD after cord blood transplantation.

Authors:  L F Newell; M E D Flowers; T A Gooley; F Milano; P A Carpenter; P J Martin; C Delaney
Journal:  Bone Marrow Transplant       Date:  2013-04-15       Impact factor: 5.483

Review 7.  Umbilical cord blood transplantation: the first 25 years and beyond.

Authors:  Karen K Ballen; Eliane Gluckman; Hal E Broxmeyer
Journal:  Blood       Date:  2013-05-14       Impact factor: 22.113

Review 8.  Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma.

Authors:  Max Schlaak; Juliane Pickenhain; Sebastian Theurich; Nicole Skoetz; Michael von Bergwelt-Baildon; Peter Kurschat
Journal:  Cochrane Database Syst Rev       Date:  2013-08-29

9.  Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.

Authors:  Judith A E Somers; Eric Braakman; Bronno van der Holt; Eefke J Petersen; Erik W A Marijt; Cynthia Huisman; Kees Sintnicolaas; Machteld Oudshoorn; Marlies E Groenendijk-Sijnke; Anneke Brand; Jan J Cornelissen
Journal:  Haematologica       Date:  2014-08-08       Impact factor: 9.941

Review 10.  Background and future considerations for human cord blood hematopoietic cell transplantation, including economic concerns.

Authors:  Hal E Broxmeyer; Sherif Farag
Journal:  Stem Cells Dev       Date:  2013-12       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.